21.UR-GE.017
Dokuz Eylul National Health Industries Export and International Competitiveness Development Project
On August 17, 2022, DEPARK applied as Turkey’s first specialized health technopark within the scope of the Decree on Export Supports, which entered into force with the Presidential Decree No. 5973 dated August 17, 2022. This initiative was realized within the framework of the circular on the implementation of Development of International Competitiveness Projects.
The project, which received preliminary approval on November 10, 2021, was introduced with the launch held on January 11, 2022 at Dokuz Eylül University 15 July Health and Arts Campus. The “Dokuz Eylül National Health Industries Export and International Competitiveness Development Project” with project code 21.UR-GE.017, developed under the leadership of DEPARK and in cooperation with Dokuz Eylül National Health Industries Association (DUSED), was officially approved by the Ministry of Trade on June 11, 2022.
Within the scope of the project, 10 DEPARK companies operating in various fields such as software, biotechnology, nanotechnology, pharmaceuticals, medical devices and food, 4 Istanbul companies, 3 Izmir companies, 3 Ankara companies and 1 Gaziantep company came together to form a strong health cluster.
Launched with a $3,000,000 budget, the first activity of this health cluster was held on 5 – 6 December 2022 with a training program titled “Competitive Strategies and Strategic Management”. 17 companies included in the project took part in the event organized at Izmir Beyond Hotel. Then, on April 12 – 13, 2023, the training program titled “Finding Customers and Sales in International Markets” was successfully completed at Izmir Beyond Hotel with the participation of many companies participating in the project.
These projects aim to increase Turkey’s export capacity and international competitiveness in the healthcare industry. These innovative steps, realized in cooperation with DEPARK and DUSED, will contribute significantly to our country having a voice in the healthcare industry on a global scale.